RE:RE:RE:RE:RE:RE:RE:Re: Up 39.39% in one weekTencents wrote: This is where the message gets mixed up
ceapro never talked about a biopharma company
its message from the ceo has always been
we are an expertise biotechnology company at extracting from plants and we plan to move to being a natural ingredient pharmaceutical/ nutritional company
No. It has always talked about transitionng to a biopharma. Its goal has been to turn its two active ingredients(beta glucan, avenanthramide) into pharma-grade products. It has run a beta glucan pill clinical trial. It is running a pharma-grade avenanthramide trial now. It is working towards a fibrosis clinical trial. It is developing wound healing applications for avenanthramide and beta glucan that can complement medical products. Ronnie Miller from the world's largest biotech company has joined.
CZO's news releases go well beyond:
"Ceapro adds further value to its extracts by supporting their use in cosmeceutical, nutraceutical and therapeutics products for humans and animals. Ceapro has a broad range of expertise in natural product chemistry, microbiology, biochemistry, immunology and process engineering. These skills merge in the fields of active ingredients, biopharmaceuticals and drug-delivery solutions. For more information on Ceapro, please visit Ceapro’s website at www.ceapro.com."